Get started
GENETIC TECHNOLOGIES LIMITEDGENETIC TECHNOLOGIES LIMITEDGENETIC TECHNOLOGIES LIMITED

GENETIC TECHNOLOGIES LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

GTG chart


Full chart

GTG upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.45 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.094 AUD
Net income (FY)
‪−12.02 M‬ AUD
Revenue (FY)
‪7.66 M‬ AUD
Shares float
‪230.94 M‬
Beta (1Y)
0.68

Employees


Employees (FY)
58
Change (1Y)
−2 −3.33%
Revenue / Employee (1Y)
‪88.09 K‬ AUD
Net income / Employee (1Y)
‪−138.12 K‬ AUD

About GENETIC TECHNOLOGIES LIMITED


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Simon Morriss
Website
genetype.com
Headquarters
Fitzroy
Founded
1987
ISIN
AU000000GTG7
FIGI
BBG000MGW2P2
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

GTG news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GTG is 0.039 AUD — it has increased by 2.63% in the past 24 hours. Watch GENETIC TECHNOLOGIES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange GENETIC TECHNOLOGIES LIMITED stocks are traded under the ticker GTG.
GTG reached its all-time high on Aug 15, 1990 with the price of 4,424.800 AUD, and its all-time low was 0.036 AUD and was reached on Aug 8, 2024. View more price dynamics on GTG chart.
See other stocks reaching their highest and lowest prices.
GTG stock is 2.56% volatile and has beta coefficient of 0.68. Track GENETIC TECHNOLOGIES LIMITED stock price on the chart and check out the list of the most volatile stocks — is GENETIC TECHNOLOGIES LIMITED there?
Today GENETIC TECHNOLOGIES LIMITED has the market capitalization of ‪9.45 M‬, it has decreased by −5.00% over the last week.
Yes, you can track GENETIC TECHNOLOGIES LIMITED financials in yearly and quarterly reports right on TradingView.
GENETIC TECHNOLOGIES LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
GTG net income for the last half-year is ‪−5.60 M‬ AUD, while the previous report showed ‪−6.42 M‬ AUD of net income which accounts for 12.79% change. Track more GENETIC TECHNOLOGIES LIMITED financial stats to get the full picture.
No, GTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 58.00 employees. See our rating of the largest employees — is GENETIC TECHNOLOGIES LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETIC TECHNOLOGIES LIMITED EBITDA is ‪−10.22 M‬ AUD, and current EBITDA margin is −157.16%. See more stats in GENETIC TECHNOLOGIES LIMITED financial statements.
Like other stocks, GTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETIC TECHNOLOGIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETIC TECHNOLOGIES LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETIC TECHNOLOGIES LIMITED stock shows the sell signal. See more of GENETIC TECHNOLOGIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.